Terminated NA INTERVENTIONAL 1-arm NCT00748085

CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) (ICEtheMAD)

A Multi-Center Study of CryoSpray Ablation(tm)in Malignant Airway Disease to Determine, Safety, and Tissue Effect in the Lung (ICE the MAD)

Sponsor: CSA Medical, Inc.

Conditions Lung Cancer Mesothelioma

Interventions CryoSpray Ablation

Updated 7 times since 2017 Last updated: Jun 30, 2015 Started: Oct 31, 2008 Primary completion: Jul 31, 2009 Completion: Aug 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Business Reasons

Other terminated trials from CSA Medical, Inc.

More terminations from CSA Medical, Inc.

Other Lung Cancer trials with similar outcome

Browse all Lung Cancer trials

Listed as NCT00748085, this NA trial focuses on Lung Cancer and Mesothelioma and remains terminated or withdrawn. Sponsored by CSA Medical, Inc., it has been updated 7 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2023 — Jul 2024 [monthly]

Terminated NA
Dec 2022 — Jan 2023 [monthly]

Terminated NA
Jan 2021 — Dec 2022 [monthly]

Terminated NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CSA Medical, Inc.

Data source: CSA Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States